{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:31:57Z","timestamp":1794573117266,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14085-0","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:39:51Z","timestamp":1744645191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Classical Kaposi sarcoma: an \u0131nsight into demographic characteristics and survival outcomes"],"prefix":"10.1186","volume":"25","author":[{"given":"Engin Eren","family":"Kavak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u00fcksel","family":"\u00dcr\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"14085_CR1","doi-asserted-by":"crossref","unstructured":"Kaposi. Idiopathisches multiples pigmentsarkom der Haut. Archiv f\u00fcr Dermatologie und Syphilis. 1872\u00a0;4(2):265\u2013273.","DOI":"10.1007\/BF01830024"},{"issue":"10","key":"14085_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/QAD.0b013e3283031a8a","volume":"22","author":"F Lanternier","year":"2008","unstructured":"Lanternier F, et al. Kaposi\u2019s sarcoma in HIV-negative men having sex with men. AIDS. 2008;22(10):1163\u20138.","journal-title":"AIDS"},{"key":"14085_CR3","unstructured":"Ferlay J, et al. Global Cancer Observatory: Cancer Today (Version 1.1). Lyon, France: International Agency for Research on Cancer. 2024. Available from: https:\/\/www.gco.iarc.who.int\/today. Accessed [DD Month YYYY]. [Google Scholar]."},{"issue":"14","key":"14085_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","volume":"342","author":"K Antman","year":"2000","unstructured":"Antman K, Chang Y. Kaposi\u2019s Sarcoma. N Engl J Med. 2000;342(14):1027\u201338.","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"14085_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000492112","volume":"234","author":"S Yazici","year":"2018","unstructured":"Yazici S, et al. Retrospective analysis of 91 kaposi\u2019s sarcoma cases: a single-center experience and review of the literature. Dermatology. 2018;234(5\u20136):205\u201313.","journal-title":"Dermatology"},{"issue":"2","key":"14085_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1468-3083.2003.00670.x","volume":"17","author":"FM Buonaguro","year":"2003","unstructured":"Buonaguro FM, et al. Kaposi\u2019s sarcoma: aetiopathogenesis, histology and clinical features. J Eur Acad Dermatol Venereol. 2003;17(2):138\u201354.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"14085_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1054-3589(07)56016-3","volume":"56","author":"PC Angeletti","year":"2008","unstructured":"Angeletti PC, Zhang L, Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol. 2008;56:509\u201357.","journal-title":"Adv Pharmacol."},{"issue":"5192","key":"14085_CR8","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, et al. Identification of herpesvirus-like DNA sequences in AIDS-Sssociated Kaposi\u2019s Sarcoma. Science. 1994;266(5192):1865\u20139.","journal-title":"Science"},{"issue":"2","key":"14085_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/QCO.0b013e3280143919","volume":"20","author":"F Pica","year":"2007","unstructured":"Pica F, Volpi A. Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis. 2007;20(2):152\u20136.","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"14085_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaad.2008.05.001","volume":"59","author":"RA Schwartz","year":"2008","unstructured":"Schwartz RA, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59(2):179\u2013206 207-8.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"14085_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1089>3.0.CO;2-8","volume":"91","author":"F Vitale","year":"2001","unstructured":"Vitale F, et al. Kaposi\u2019s sarcoma herpes virus and Kaposi\u2019s sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer. 2001;91(4):588\u201391.","journal-title":"Int J Cancer"},{"issue":"2","key":"14085_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/030089160308900203","volume":"89","author":"V Ascoli","year":"2003","unstructured":"Ascoli V, et al. Variability in the incidence of classic Kaposi\u2019s sarcoma in the Veneto region. Northern Italy Tumori. 2003;89(2):122\u20134.","journal-title":"Northern Italy Tumori"},{"issue":"1","key":"14085_CR13","first-page":"83","volume":"13","author":"L Brambilla","year":"2003","unstructured":"Brambilla L, et al. Staging of classic Kaposi\u2019s sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003;13(1):83\u20136.","journal-title":"Eur J Dermatol"},{"issue":"2","key":"14085_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1590\/S0365-05962012000200005","volume":"87","author":"RM Tiussi","year":"2012","unstructured":"Tiussi RM, et al. Kaposi\u2019s Sarcoma: clinical and pathological aspects in patients seen at the Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes - Vit\u00f3ria - Esp\u00edrito Santo - Brazil. An Bras Dermatol. 2012;87(2):220\u20137.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"14085_CR15","first-page":"122","volume":"42","author":"\u00d6 Su","year":"2008","unstructured":"Su \u00d6, et al. Clinical features, presence of human herpesvirus-8 and treatment results in classic Kaposi sarcoma. Turkderm-Turk Arch Dermatol Venereol. 2008;42(4):122\u20136.","journal-title":"Turkderm-Turk Arch Dermatol Venereol"},{"key":"14085_CR16","first-page":"21","volume":"17","author":"BD G\u00fcn","year":"2007","unstructured":"G\u00fcn BD, et al. Klasik Kaposi Sarkomu. Turkiye Klinikleri J Dermatol. 2007;17:21\u20135.","journal-title":"Turkiye Klinikleri J Dermatol"},{"key":"14085_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1749-6632.1984.tb37157.x","volume":"437","author":"B Safai","year":"1984","unstructured":"Safai B. Kaposi\u2019s sarcoma: a review of the classical and epidemic forms. Ann N Y Acad Sci. 1984;437:373\u201382.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"14085_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/sj.bjc.6601313","volume":"89","author":"E Guttman-Yassky","year":"2003","unstructured":"Guttman-Yassky E, et al. Epidemiology of classic Kaposi\u2019s sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer. 2003;89(9):1657\u201360.","journal-title":"Br J Cancer"},{"issue":"4 Pt 2","key":"14085_CR19","first-page":"570","volume":"77","author":"A Kaloterakis","year":"1984","unstructured":"Kaloterakis A, et al. Mediterranean Kaposi\u2019s sarcoma: preliminary communication about 131 cases. Bull Soc Pathol Exot Filiales. 1984;77(4 Pt 2):570\u20131.","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"1","key":"14085_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-5945-11-15","volume":"11","author":"H Errihani","year":"2011","unstructured":"Errihani H, et al. Classic Kaposi\u2019s sarcoma in morocco: clinico -epidemiological study at the national institute of oncology. BMC Dermatol. 2011;11(1):15.","journal-title":"BMC Dermatol"},{"issue":"5","key":"14085_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0889-8588(05)70382-8","volume":"10","author":"BJ Dezube","year":"1996","unstructured":"Dezube BJ. Clinical presentation and natural history of AIDS\u2013related Kaposi\u2019s sarcoma. Hematol Oncol Clin North Am. 1996;10(5):1023\u20139.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"14085_CR22","first-page":"Cd003256","volume":"8","author":"OF Gbabe","year":"2014","unstructured":"Gbabe OF, et al. Treatment of severe or progressive Kaposi\u2019s sarcoma in HIV-infected adults. Cochrane Database Syst Rev. 2014;8(8):Cd003256.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"14085_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1158\/1055-9965.EPI-04-0598","volume":"14","author":"EE Brown","year":"2005","unstructured":"Brown EE, et al. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev. 2005;14(3):633\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"14085_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"14085_CR25","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1158\/1055-9965.EPI-08-0671","volume":"17","author":"LA Anderson","year":"2008","unstructured":"Anderson LA, et al. Risk factors for classical kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomark Prev. 2008;17(12):3435\u201343.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"14085_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/cncr.21614","volume":"106","author":"E Guttman-Yassky","year":"2006","unstructured":"Guttman-Yassky E, et al. Classic Kaposi sarcoma. Cancer. 2006;106(2):413\u20139.","journal-title":"Cancer"},{"issue":"10","key":"14085_CR27","first-page":"1121","volume":"10","author":"LJ Conley","year":"1996","unstructured":"Conley LJ, et al. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996;10(10):1121\u20136.","journal-title":"AIDS"},{"issue":"3","key":"14085_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/jso.20090","volume":"87","author":"RA Schwartz","year":"2004","unstructured":"Schwartz RA. Kaposi\u2019s sarcoma: an update. J Surg Oncol. 2004;87(3):146\u201351.","journal-title":"J Surg Oncol"},{"issue":"10","key":"14085_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-4362.1997.00284.x","volume":"36","author":"JD Stratigos","year":"1997","unstructured":"Stratigos JD, et al. Classic Kaposi\u2019s sarcoma in Greece: a clinico-epidemiological profile. Int J Dermatol. 1997;36(10):735\u201340.","journal-title":"Int J Dermatol"},{"issue":"6","key":"14085_CR30","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/1097-0142(19800315)45:6<1472::AID-CNCR2820450629>3.0.CO;2-A","volume":"45","author":"B Safai","year":"1980","unstructured":"Safai B, et al. Association of Kaposi\u2019s sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer. 1980;45(6):1472\u20139.","journal-title":"Cancer"},{"issue":"10","key":"14085_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1684\/bdc.2012.1636","volume":"99","author":"Y Akasbi","year":"2012","unstructured":"Akasbi Y, et al. Non-HIV Kaposi\u2019s sarcoma: a review and therapeutic perspectives. Bull Cancer. 2012;99(10):92\u20139.","journal-title":"Bull Cancer"},{"key":"14085_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-015-1076-1","volume":"8","author":"B Vincenzi","year":"2015","unstructured":"Vincenzi B, D\u2019Onofrio L, Frezza AM, Grasso RF, Fausti V, Santini D, et al. Classic Kaposi Sarcoma: to treat or not to treat? BMC Res Notes. 2015;8:1\u20134.","journal-title":"BMC Res Notes."},{"issue":"6","key":"14085_CR33","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/sj.jid.5701215","volume":"128","author":"G Di Lorenzo","year":"2008","unstructured":"Di Lorenzo G, et al. Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi\u2019s sarcoma: a multicenter study. J Investig Dermatol. 2008;128(6):1578\u201380.","journal-title":"J Investig Dermatol"},{"issue":"5","key":"14085_CR34","doi-asserted-by":"publisher","first-page":"e32866","DOI":"10.1097\/MD.0000000000032866","volume":"102","author":"N Paksoy","year":"2023","unstructured":"Paksoy N, et al. Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: a real-life study. Medicine (Baltimore). 2023;102(5):e32866.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"14085_CR35","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/jdv.12349","volume":"28","author":"XJ Wu","year":"2014","unstructured":"Wu XJ, et al. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China. J Eur Acad Dermatol Venereol. 2014;28(11):1545\u201352.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14085-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14085-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14085-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:39:56Z","timestamp":1744645196000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14085-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14085"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14085-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was granted by the Ankara University Faculty of Medicine Hospital on 10 June 2022, with the decision number E-32557014\u2013604.01.02\u2013543229. Written informed consent was obtained from all participants, and the study was planned and conducted according to the ethical principles outlined in the 1964 Declaration of Helsinki and its 2008 revision.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"690"}}